Laboratorio de Química de Productos Naturales, Instituto de Química de Recursos Naturales, Universidad de Talca, Casilla 747, Talca, Chile.
Molecules. 2010 Oct 21;15(10):7378-94. doi: 10.3390/molecules15107378.
Following our studies on the gastroprotective effect and cytotoxicity of terpene derivatives, new amides were prepared from the diterpene 8(17)-labden-15,19-dioic acid (junicedric acid) and its 8(9)-en isomer with C-protected amino acids (amino acid esters). The new compounds were evaluated for their gastroprotective effect in the ethanol/HCl-induced gastric lesions model in mice, as well as for cytotoxicity using the following human cell lines: normal lung fibroblasts (MRC-5), gastric adenocarcinoma cells (AGS) and liver hepatocellular carcinoma (Hep G2). A dose-response experiment showed that at 25 mg/kg the C-15 leucyl and C-15,19-dileucylester amides of junicedric acid reduced gastric lesions by about 65.6 and 49.6%, respectively, with an effect comparable to lansoprazole at 20 mg/kg (79.3% lesion reduction). The comparison of the gastroprotective effect of 18 new amino acid ester amides was carried out at a single oral dose of 25 mg/kg. Several compounds presented a strong gastroprotective effect, reducing gastric lesions in the 70.9-87.8% range. The diprolyl derivative of junicedric acid, the most active product of this study (87.8% lesion reduction at 25 mg/kg) presented a cytotoxicity value comparable with that of the reference compound lansoprazole. The structure-activity relationships are discussed.
在对萜烯衍生物的胃保护作用和细胞毒性进行研究之后,我们用二萜 8(17)-贝壳杉烯-15,19-二酸(朱尼酸)及其 8(9)-烯异构体与 C 保护的氨基酸(氨基酸酯)制备了新酰胺。我们评估了这些新化合物在乙醇/HCl 诱导的小鼠胃损伤模型中的胃保护作用,以及使用以下人类细胞系的细胞毒性:正常肺成纤维细胞(MRC-5)、胃腺癌细胞(AGS)和肝肝癌细胞(Hep G2)。剂量反应实验表明,在 25mg/kg 时,朱尼酸的 C-15 亮氨酸和 C-15,19-二亮氨酸酯酰胺分别减少了约 65.6%和 49.6%的胃损伤,其效果可与 20mg/kg 的兰索拉唑(79.3%损伤减少)相媲美。在 25mg/kg 的单次口服剂量下,对 18 种新氨基酸酯酰胺的胃保护作用进行了比较。几种化合物表现出很强的胃保护作用,将胃损伤减少到 70.9-87.8%的范围内。朱尼酸的二丙基衍生物是本研究最活跃的产物(25mg/kg 时减少 87.8%的损伤),其细胞毒性值与参比化合物兰索拉唑相当。讨论了结构-活性关系。